![](https://investorshub.advfn.com/uicon/564105.png?cb=1547105359)
Wednesday, May 22, 2019 9:19:09 AM
"Analysts at Piper Jaffray initiated coverage on Titan Medical Inc. (NASDAQ: TMDI) with an Overweight rating. The price target for Titan Medical is set to $6. Titan Medical shares closed at $2.71 on Tuesday.
Piper Jaffray initiated coverage on Transenterix Inc (NYSE: TRXC) with a Neutral rating. The price target for Transenterix is set to $1.60. Transenterix closed at $1.26 on Tuesday."
Why would they set Trixie so high?
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM